Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status

Sahar Al-Ayyoubi1, Hala Gali-Muhtasib

  • 1Department of Biology, The American University of Beirut, Beirut, Lebanon.

Molecular Carcinogenesis
|December 29, 2006
PubMed

Insights

Gallotannin (GT) inhibits colon cancer cell growth by arresting the cell cycle. It induces apoptosis in p53-deficient cells, revealing its chemopreventive potential through p53-independent mechanisms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Natural Products Chemistry

Background:

  • Plant polyphenols, like Gallotannin (GT), exhibit anticarcinogenic properties.
  • Previous studies indicated GT's efficacy in preventing colon tumors in mice.
  • The precise molecular mechanisms underlying GT's chemopreventive effects remain largely unelucidated.

Purpose of the Study:

  • To investigate the molecular mechanisms of Gallotannin (GT) in colon cancer chemoprevention.
  • To determine GT's effects on human colon cancer cell lines with varying p53 statuses.
  • To identify potential molecular targets of GT in colon cancer therapy.

Main Methods:

  • Utilized isogenic HCT-116 colon cancer cell lines (p53+/+ and p53-/-) and normal intestinal cells (FHs 74Int).
  • Employed DNA flow cytometry to analyze cell-cycle progression and apoptosis.
  • Assessed protein and transcript levels of key cell-cycle regulators (p53, p21, cyclin D1, pRb) and apoptosis markers (Bax, Bcl-2).

Main Results:

  • GT inhibited the growth of HCT-116 cells and induced S-phase arrest in both p53+/+ and p53-/- lines.
  • In p53+/+ cells, GT increased p53 and p21 levels, decreased cyclin D1, pRb, and altered the Bax/Bcl-2 ratio, without inducing apoptosis.
  • GT induced significant apoptosis in p53-/- cells, marked by increased Bax/Bcl-2 ratios.

Conclusions:

  • Gallotannin (GT) inhibits colon cancer cell proliferation through p53-independent cell-cycle arrest.
  • GT demonstrates differential induction of apoptosis based on the p53 status of colon cancer cells.
  • These findings support GT's potential as a chemopreventive agent with distinct molecular actions.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...